Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio
Samir Vyas, Country Manager, Agilent India says India companies are now moving into the global biopharma market and gives his…
DGHS asks KSRPO to ensure continuation of Drugs Act in Karnataka
Action is taken based on the grievances received by the CDSCO
Antibodies generated by COVID-19 vaccines less effective against some variants: US Study
According to the scientists, the two strains first described in Brazil and Japan were five to seven times more resistant, compared…
QUAD pledges to supply billion doses of COVID-19 vaccine across Asia by 2022
The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change,…
J&J single-shot COVID-19 vaccine gets Emergency Use Listing by WHO
Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including…
Novavax vaccine shows 96 per cent efficacy against original coronavirus, 86 per cent against UK…
Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India
Abbott forms Pandemic Defense Coalition
It is a global scientific network dedicated to the early detection of, and rapid response to, future pandemic threats
China continues to lead high value oncology deals in APAC: GlobalData
High-value deals have dominated the Asia-Pacific (APAC) pharma strategic partnership landscape in 2020. Within the region, China…
Hikma, GSK stop talks over potential buyout deal of Egypt, Tunisia assets
Hikma had said in January that it was planning to buy those assets
Vir, GSK to seek EUA for COVID-19 antibody therapy
Vir and GSK also said that a new laboratory study showed the therapy, VIR-7831, was equally effective against the UK, South…